XML 47 R26.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
12 Months Ended
Feb. 01, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments
The fair value of the Company’s financial instruments as of February 1, 2025 and February 3, 2024 are as follows:

($000)20242023
Cash and cash equivalents (Level 1)
$4,730,744 $4,872,446 
Restricted cash and cash equivalents (Level 1)
$65,718 $62,995 
Schedule of Fair Value of Assets and Liabilities The fair value measurement for funds with quoted market prices in active markets (Level 1) are as follows:
($000)20242023
Nonqualified deferred compensation program (Level 1)$196,786 $165,582